Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of XW003 Injection in Chinese Adolescents With Obesity
Sponsor: Hangzhou Sciwind Biosciences Co., Ltd.
Summary
The aim of the study is to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of XW003 injection in Chinese adolescents with obesity
Official title: A Randomized, Double-blind, Placebo-controlled Phase Ib Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Dosing of XW003 Injection in Chinese Adolescents With Obesity
Key Details
Gender
All
Age Range
12 Years - 18 Years
Study Type
INTERVENTIONAL
Enrollment
48
Start Date
2025-08-25
Completion Date
2026-12-31
Last Updated
2026-01-28
Healthy Volunteers
Yes
Conditions
Interventions
XW003 injection
Subcutaneous injection
placebo with matching volume
Subcutaneous injection
Locations (1)
Qilu Hospital of Shandong University
Jinan, Shandong, China